Endothelial vascular cell adhesion molecule 1 expression is suppressed by melanoma and carcinoma
about
Approaches to improve tumor accumulation and interactions between monoclonal antibodies and immune cellsWays to enhance lymphocyte trafficking into tumors and fitness of tumor infiltrating lymphocytesCharacteristics of tertiary lymphoid structures in primary cancersMolecular pathways: not a simple tube--the many functions of blood vesselsModulation of L-selectin ligand expression during an immune response accompanying tumorigenesis in transgenic miceControl of immune cell entry through the tumour vasculature: a missing link in optimising melanoma immunotherapy?T cells in the human metastatic melanoma microenvironment express site-specific homing receptors and retention integrinsAngiogenesis modulates the tumour immune response.Systemic distribution and tumor localization of adoptively transferred lymphocytes in mice: comparison with physiologically based pharmacokinetic model.Down-modulation of monocyte transendothelial migration and endothelial adhesion molecule expression by fibroblast growth factor: reversal by the anti-angiogenic agent SU6668Reprogramming the tumor microenvironment: tumor-induced immunosuppressive factors paralyze T cells.Elevated pretreatment serum levels of soluble vascular cell adhesion molecule 1 and lactate dehydrogenase as predictors of survival in cutaneous metastatic malignant melanomaAdhesion molecules: opportunities for modulation and a paradigm for novel therapeutic approaches in cancer.Hurdles to lymphocyte trafficking in the tumor microenvironment: implications for effective immunotherapy.Immune cell migration as a means to control immune privilege: lessons from the CNS and tumors.Sipuleucel-T (APC8015) for prostate cancer.Human squamous cell carcinomas evade the immune response by down-regulation of vascular E-selectin and recruitment of regulatory T cellsTargeted regulation of a lymphocyte-endothelial-interleukin-6 axis by thermal stress.Anti-angiogenesis: making the tumor vulnerable to the immune system.Intravital imaging of CD8+ T cell function in cancer.Tumor escape from immune recognition: lethal recurrent melanoma in a patient associated with downregulation of the peptide transporter protein TAP-1 and loss of expression of the immunodominant MART-1/Melan-A antigen.Leukocyte adhesion in angiogenic blood vessels. Role of E-selectin, P-selectin, and beta2 integrin in lymphotoxin-mediated leukocyte recruitment in tumor microvessels.The Role of the Tumor Vasculature in the Host Immune Response: Implications for Therapeutic Strategies Targeting the Tumor Microenvironment.Variation of tumor-infiltrating lymphocytes in human cancers: controversy on clinical significance.Tumor evasion from T cell surveillance.Prostate cancer, tumor immunity and a renewed sense of optimism in immunotherapy.Vascular cell adhesion molecule-1 (VCAM-1)--an increasing insight into its role in tumorigenicity and metastasis.T-lymphocyte homing: an underappreciated yet critical hurdle for successful cancer immunotherapy.Fine-Tuning Tumor Endothelial Cells to Selectively Kill Cancer.Imiquimod enhances IFN-gamma production and effector function of T cells infiltrating human squamous cell carcinomas of the skin.Tumor-endothelium cross talk blocks recruitment of neutrophils to endothelial cells: a novel mechanism of endothelial cell anergy.Recombinant DNA vaccines protect against tumors that are resistant to recombinant vaccinia vaccines containing the same gene.Tumor vascularity in ovarian cancer: T cells need breathing room.Tumor recognition by the cellular immune system: new aspects of tumor immunology.VEGF Neutralization Plus CTLA-4 Blockade Alters Soluble and Cellular Factors Associated with Enhancing Lymphocyte Infiltration and Humoral Recognition in Melanoma.Improving drug uptake and penetration into tumors: current and forthcoming opportunities.Enhancement of leukocyte adhesion after percutaneous irradiation in rats with hepatocellular carcinoma.Intercellular adhesion molecule-3 on endothelial cells. Expression in tumors but not in inflammatory responsesEndothelial P-selectin expression is reduced in advanced primary melanoma and melanoma metastasis.Tumor-specific T cells in human Merkel cell carcinomas: a possible role for Tregs and T-cell exhaustion in reducing T-cell responses.
P2860
Q26852287-A8A6806B-E070-407C-AC48-3B185F7946F1Q26991991-C0B152EE-74BE-4702-8978-560B3C7FCDCCQ27012852-0941E0C7-D520-44AF-8F80-DCF05AC646A5Q27025036-80CBEA43-488C-487A-86FC-60A9BC5F1FD6Q28770154-62286F0F-B52A-4A03-A04B-902BB9EDD880Q29994573-9A26D686-4F01-49A5-AB62-85DF2C6B32B4Q30408331-8D62A45D-CF1E-4C04-ACEC-01DC25B3847BQ33630427-BBF3706C-F59B-4D2C-AEDB-B3FFAFA608F7Q34775046-AE67B4F4-CCEC-4762-9C3E-DC774901042DQ35747992-F528C9C8-0E06-402F-9325-6FE8C3C98261Q35799094-80AF7499-584D-465F-B8A2-07194ABEBE2DQ36114813-40298B5F-AC5C-4C48-8548-C032D289F5C6Q36179662-3D7D5637-7136-4A27-A640-092D0A04B774Q36568984-D48D0CAE-C283-41D0-B14D-4A2802349093Q36593767-6F3EDE4F-F341-4423-8CEC-E6A360C5758BQ36613961-15FE2D64-7CB7-4F22-A2F8-57C0872D6D7CQ36916400-CAA2A249-4F2A-4B56-A898-0E3811D65030Q37063499-ED48D339-9869-4060-B6EF-7BA0765C56C9Q37148358-FE37ACA8-7476-4ACE-8772-81A48A9B0F67Q37229840-809639EA-2977-42EB-8130-831E5E679384Q37360526-8C33F0FA-7B9E-494D-B87D-DB73F96E3F9CQ37366828-71C02F1B-5B71-442C-AA95-5F94AE3633B5Q37516448-357CA1A8-2FDC-4580-AB06-0B4D379C34B0Q37945304-1FBBA0B1-3A68-4101-BDE1-A01BBCFCEC90Q37970674-BA88B127-CD90-40DB-A6B4-4310C60F39BEQ37983730-FCC16834-6853-4FA4-A3AC-1D7E586711C5Q38207560-161415E2-064A-4FC7-A405-36A1CD2399F7Q38873974-DF3EC4B2-AAFE-484C-A744-2397D8D033DFQ39406918-BA4C4F2C-F28B-404A-90BD-31BD6795DEA5Q39705893-6A2CC07D-2423-4DC0-BBB6-D2AD8B4FADBAQ39793034-AA3D31DD-9521-4458-ACC9-0CF063253993Q40712474-28BF3913-6AE0-4006-9E83-8D50EC3CA10FQ40877719-6823B2A4-AAAA-48C9-A418-179379EB6ACAQ41455911-AA0E2C9B-ED1A-497D-AD9C-D63737A905CEQ41636554-AD0B8248-4CCD-49E8-B28A-389FF96CEC8FQ41861892-2F89D9AB-3904-48EF-B318-3A7CA2C68ACDQ41873003-561CCEE8-BE4B-4D7E-9F8C-6DE8DD955ABDQ41922774-A2D02CDA-DB8B-4B67-AE28-644C5293A229Q41971783-59E7E650-7224-4D1F-B444-42595AF9735CQ42114097-BFF77450-A46D-415C-885C-5A3359F0F91C
P2860
Endothelial vascular cell adhesion molecule 1 expression is suppressed by melanoma and carcinoma
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh
1995年學術文章
@zh-hant
name
Endothelial vascular cell adhe ...... ssed by melanoma and carcinoma
@ast
Endothelial vascular cell adhe ...... ssed by melanoma and carcinoma
@en
type
label
Endothelial vascular cell adhe ...... ssed by melanoma and carcinoma
@ast
Endothelial vascular cell adhe ...... ssed by melanoma and carcinoma
@en
prefLabel
Endothelial vascular cell adhe ...... ssed by melanoma and carcinoma
@ast
Endothelial vascular cell adhe ...... ssed by melanoma and carcinoma
@en
P2093
P2860
P356
P1476
Endothelial vascular cell adhe ...... ssed by melanoma and carcinoma
@en
P2093
P2860
P304
P356
10.1084/JEM.181.2.811
P407
P577
1995-02-01T00:00:00Z